HCT/P Deviations and Reporting
|
|
- Elijah Shields
- 5 years ago
- Views:
Transcription
1 HCT/P Deviations and Reporting Sharon O Callaghan Consumer Safety Officer Division of Inspections and Surveillance Office of Compliance and Biologics Quality 13 th Annual FDA and the Changing Paradigm for HCT/P Regulations February 13-15, 2017; Alexandria, VA
2 Subpart E Additional Requirements for Establishments Described in 21 CFR CFR Applicability 21 CFR (a) Adverse Reaction Reports 21 CFR (b) Reports of HCT/P Deviations Sharon O'Callaghan 2
3 Subpart E Additional Requirements Applicability [21 CFR ] Nonreproductive HCT/Ps described in 21 CFR (a) and regulated solely under PHS Act Section 361 Not Applicable Reproductive HCT/Ps (semen, oocyte, embryo) HCT/Ps that are drugs, devices and/or biologics Sharon O'Callaghan 3
4 HCT/P Deviation Reporting [21 CFR (b)] Sharon O'Callaghan 4
5 HCT/P Deviation Means an Event: That represents a deviation from applicable regulations in this part or from applicable standards or established specifications that relate to the prevention of communicable disease transmission or HCT/P contamination; or That is an unexpected or unforeseeable event that may relate to the transmission or potential transmission of a communicable disease or may lead to HCT/P contamination [21 CFR (dd)] Sharon O'Callaghan 5
6 HCT/P Deviation Reporting All HCT/P deviations related to a distributed HCT/P Must be investigated by the manufacturer Must report any such HCT/P deviation That occurred in that facility or in a facility that performed a manufacturing step for the facility under contract, agreement, or other arrangement Only those related to core CGTP requirements [21 CFR (b)] Sharon O'Callaghan 6
7 Manufacture Manufacture means, but is not limited to, any or all steps in the recovery, processing, storage, labeling, packaging or distribution of any human cell or tissue and the screening or testing of the cell or tissue donor. [21 CFR (c)] Sharon O'Callaghan 7
8 Distribution Distribution means any conveyance or shipment (including importation or exportation) of an HCT/P that has been determined to meet all release criteria, whether or not such conveyance or shipment is entirely intrastate. [21 CFR (bb)] Sharon O'Callaghan 8
9 HCT/P Regulations Current Good Tissue Practice Requirements Core CGTPs 21 CFR (b) Requirements directly related to preventing the introduction, transmission, or spread of communicable diseases Other requirements support the core CGTPs Sharon O'Callaghan 9
10 Core CGTPs 21 CFR (b) Facilities Environmental control Equipment Supplies & reagents Recovery Processing and process controls Labeling controls Storage Receipt, predistribution shipment, and distribution Donor eligibility determinations, donor screening and donor testing Sharon O'Callaghan 10
11 When Must I Report HCT/P Deviations? You must report each such HCT/P deviation that relates to a core CGTP within 45 days of the discovery of the event. [21 CFR (b)(3)] Sharon O'Callaghan 11
12 Who Must Report HCT/P Deviations? Establishments that manufacture HCT/Ps The HCT/P deviation occurred in your facility The HCT/P occurred in a facility that performed a manufacturing step for you under contract, agreement, or other arrangement Sharon O'Callaghan 12
13 How Do I Report HCT/P and Biological Product Deviations? Report on Form FDA 3486, electronically or by mail to: Food and Drug Administration Center for Biologics Evaluation and Research Document Control Center New Hampshire Avenue WO71-G112 Silver Spring, MD ogicalproductdeviations/default.htm Sharon O'Callaghan 13
14 Deviation Reporting for Human Cells, Tissues, and Cellular and Tissue-Based Products Regulated Solely Under Section 361 of the Public Health Service Act and 21 CFR Part 1271 Draft Guidance for Industry December 2015 Sharon O'Callaghan 14
15 HCT/P and Biological Product Deviation Reporting ReportaProblem/BiologicalProductDeviations/default.htm Regulations: 21 CFR , , (b) FDA Form PDF format Electronic Form Instructions for completing forms Deviation Codes for HCT/Ps & other biological products Product Codes for deviation reporting purposes Summary Reports Sharon O'Callaghan 15
16 Questions About HCT/P Deviation Reporting? account for questions about HCT/P deviations: Contact CBER s Division of Inspections and Surveillance Sharon O Callaghan (240) Sharon O'Callaghan 16
17 Vision for CBER CBER uses sound science and regulatory expertise to: Protect and improve public and individual health in the US and, where feasible, globally Facilitate development, approval of and access to safe and effective products and promising new technologies Strengthen CBER as a preeminent regulatory organization for biologics INNOVATIVE TECHNOLOGY ADVANCING PUBLIC HEALTH Sharon O'Callaghan 17
18 Public Access to CBER CBER website: Consumer Affairs Branch (CAB) Phone: or Manufacturers Assistance and Technical Training Branch (MATTB) Phone: Follow us on Twitter Sharon O'Callaghan 18
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors FDA Institutional Review Board Inspections Additional copies are available from: Good Clinical Practice Program, HF-34 Office of
More informationSOP 407: PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS
University of Oklahoma Office of Human Research Participant Protection : PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS 1. POLICY Protocol deviations and unanticipated problems may be discovered in a variety
More information(y9. &i?r, JUL t Certified-Return Receipt Requested WARNING LE7TER
... (y9 &i?r, DEPARTMENT OF HEALTH a HUMAN SERVICES Public Health Service Food and Drug Admini~ation Center for Biologics Evaluation and Rem 1401 Rockville Pike Rockville MD 20852-1448 JUL t 71997 Certified-Return
More informationGuidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval
Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval Additional copies are available from: Office of Communication Division of Drug Information,
More informationEMERGENCY USE 03/02/2016
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program EMERGENCY USE 03/02/2016 Emergency Exemption for an Investigational Drug or Biologic or Unapproved Device Emergency use of an investigational
More informationReporting an Unanticipated Problem Involving Risks to Subjects or Others (UPIRTSO) to the IRB
INSTITUTIONAL REVIEW BOARD (IRB) OFFICE FOR HUMAN RESEARCH PROTECTION Reporting an Unanticipated Problem Involving Risks to Subjects or Others (UPIRTSO) to the IRB UPIRTSO Flowchart Content Applies To
More informationUniversity of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Post-Approval Submissions
Reliance Agreement Guidance: Post-Approval Submissions This document is designed to provide guidance on the requirements and submission processes for Amendments, Continuing Review, Reportable Events, and
More informationChildren s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures. IRB Review Processes
Page: 1 of 8 I. PURPOSE II. III. IV. The purpose of this standard operating procedure is to describe IRB review processes, including pre-review, review, and post-review procedures. POLICY STATEMENT The
More informationUNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW I. PURPOSE This document outlines the required elements of Institutional Review Board (IRB)
More information510(k) SUMMARY K EIDOSMVED LLC OEC EDG Depth Gauge Page 1 of 2, 510(k) Summary
510(k) SUMMARY K091992 EIDOSMVED LLC OEC -9 2009 EDG Depth Gauge Page 1 of 2, 510(k) Summary September 30, 2009 Date Prepared John Kim Summay prepared by: Eidosmed LIC 2312 Wabansia Unit 1 Chicago 1160647
More informationDate Effective 4/21/2008 Identification
OHSU Research Integrity Office Human Research Protection Program Policies & Procedures Title: Research with Medical Devices Date Effective 4/21/2008 Identification Supersedes P&P dated: Page 1 of BACKGROUND
More informationScreening and Enrollment Log. List of all subjects screened and all subjects screened and enrolled in the study.
Contents Screening and Enrollment Log... 2 Regulatory Approval... 3 Protocol, Amendments and Signature Pages... 4 Investigational Product Information - 1... 5 Investigational Product Information - 2...
More informationSOP 801: Investigator Qualifications and Responsibilities
1. POLICY University of Oklahoma : Investigator Qualifications and Responsibilities The purpose of this policy is to outline the qualifications and responsibilities of the principal investigator and key
More informationPIPELINE SAFETY. Darin Burk, Manager Pipeline Safety. January 28, 2014
PIPELINE SAFETY Darin Burk, Manager Pipeline Safety January 28, 2014 Congressional Delegation of Authority Pipeline Safety Act of 1968 Congress Delegated Inspection and Enforcement Authority to the Secretary
More informationI. Summary. II. Responsibilities
IRB Procedure 11a: Continuing Review Revision Date: May 15, 2007, revised November 11, 2009, revision July 17, 2010, revised March 1, 2011, revised February 9, 2015 I. Summary The IRB policy is to make
More informationHUD and HDE Topics. Humanitarian Use Device and. Humanitarian Use Device. Humanitarian Device Exemption
Humanitarian Use Device Humanitarian Device Exemption Marian Serge, RN Division of Bioresearch Monitoring Center for Devices and Radiological Health Marian.Serge@fda.hhs.gov 1 HUD and HDE Topics Regulations//Guidance
More informationUNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH I. PURPOSE This document outlines the required elements of University of Tennessee
More informationInvestigator Manual. If you have questions about whether an activity requires IRB review, contact the IRB Office.
CM-999 001 1 May 2015 Page 1 of 5 What is the purpose of this manual? This document is designed to guide you through policies and procedures related to the conduct of human research that are specific to
More informationUniversity of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP)
University of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP) I. OVERVIEW The purpose of this Standard Operating Procedure is to define a process for all University of Iowa
More informationStudy Management SM STANDARD OPERATING PROCEDURE FOR Interactions with the Institutional Review Board (IRB)
Study Management SM 302.00 STANDARD OPERATING PROCEDURE FOR Interactions with the Institutional Review Board (IRB) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval:
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Inspections, Compliance, Enforcement, and Criminal Investigations Burzynski Research Institute / IRB Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring,
More informationCONTINUING REVIEW 3/7/2016
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program Introduction CONTINUING REVIEW 3/7/2016 Federal regulations require that DUHS has written procedures which the IRB will follow for (a) conducting
More informationVia Federal Express Rockville, MD 20850
DEPARTMENT OF HEAKTH & HUMAN SERVICES JUL 8 -- WARNING LETTER Food and Drug Administration Center for Devices and Radiological Health 2098 Gaither Road Via Federal Express Rockville, MD 20850 Gordon Binder
More informationInstitutional Responsibilities Under A Federalwide Assurance
Institutional Responsibilities Under A Federalwide Assurance Lisa A. Rooney, JD Director Aegis Compliance & Ethics Center, LLP June 6, 2013 1 Questions There will be a q&a session at the end of the program.
More informationThe Children s Hospital of Philadelphia Committee for the Protection of Human Subjects Policies and Procedures. Cooperative Agreements
Page: 1 of 8 I. PURPOSE This standard operating procedure describes the IRB s procedures for review and oversight of research conducted under a cooperative agreement with an external (outside) IRB. It
More informationSafety Data Sheet Revision Date: June 21, Section 1 Product and Company Identification
1.1 Manufacturer Information Quidel Corporation Phone: 1.800.874.1517 Web: quidel.com 2005 East State Street, Suite 100 Fax: 1.740.592.9820 E-mail: qehs@quidel.com Athens, OH 45701 Emergency (24-Hour):
More informationDOCUMENTATION OF IRB DISCUSSIONS AND DECISIONS ( IRB MINUTES)
POLICY # RESEARCH POLICY & PROCEDURE Approval Date: 12-19-2008 CTM Review Cycle: 1 2 3 Revision Dates: AAHRPP DOC # 54 Responsible Office: Research Compliance DOCUMENTATION OF IRB DISCUSSIONS AND DECISIONS
More information7.0 DEVIATION and EXCEPTION of a PREVIOUSLY APPROVED PROTOCOL
7.0 DEVIATION and EXCEPTION of a PREVIOUSLY APPROVED PROTOCOL 7.1 OBJECTIVE To describe the policies and procedures for reviewing a modification or a deviation/exception to a previously approved protocol.
More informationCurrent Status: Active PolicyStat ID: Origination: 04/2018 Effective: 04/2018 Approved: 04/2018 Last Revised: 04/2018 Expiration: 04/2021
Current Status: Active PolicyStat ID: 4870880 Origination: 04/2018 Effective: 04/2018 Approved: 04/2018 Last Revised: 04/2018 Expiration: 04/2021 Owner: Policy Area: References: Suzanne Sharland-Hemmila:
More informationGuidance for Industry
Guidance for Industry Granularity Document Annex to M4: Organization of the CTD U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
More informationInitial Review. Approved By: Michele Kennett, JD, MSN, LLM Associate Vice Chancellor for Research. Table of Contents
Institutional Review Board University of Missouri-Columbia Standard Operating Procedure Initial Review Initial Review Effective Date: September 1, 2004 Original Approval Date: September 1, 2004 Revision
More informationI. Summary. II. Responsibilities
IRB Procedures 9a: Full review procedures Revision date: October 6, 2008, revision November 11, 2009, revision July 17, 2010, revised January 27, 2011, revised February 9, 2015, revised October 15, 2015
More informationInstitutional Review Board - Restriction s Impo sed
('/(.s~ ll $L'P.VIC' s '0 ~t: 'o
More informationRESEARCH PROTECTIONS OFFICE
Page 1 of 5 RESEARCH PROTECTIONS OFFICE Single IRB RPO Human Subjects Research Single IRB Single IRB Definitions Authorization Agreement/Reliance Agreement written agreement between two or more institutions
More information21 CFR Part 56 - Institutional Review Boards
INFORMATION SHEETS Guidance for Institutional Review Boards and Clinical Investigators 1998 Update Appendix C 21 CFR Part 56 - Institutional Review Boards Subpart A General Provisions 56.101 Scope. 56.102
More informationJUN L WARNING LETTER VIA FEDERAL EXPRESS
DEPARTMENT OF HEALTH, & HUMAINi SEF.'`viLES JUN L 2 2006., WARNING LETTER VIA FEDERAL EXPRESS Patricia Hardenbergh, MD Chairperson, Vail Valley Medical Center IRB 181 West Meadow Drive, Suite 100 Vail,
More informationPolicy Number: 42 Title: Investigational Devices Date of Last Revision: 06/12/2008; 07/22/2010; 05/29/2013; 05/01/2016; 10/16/2018
University of California, Irvine Human Research Protections Standard Operating Policies and Procedures Policy Number: 42 Title: Investigational Devices Date of Last Revision: 06/12/2008; 07/22/2010; 05/29/2013;
More informationMATERIAL SAFETY DATA SHEET MANUFACTURER NAME: CORETEX PRODUCTS
(Page 1 of 8) This form is regarded to be in compliance with 29 CFR Part 1910.1200 SECTION 1: PRODUCT AND COMPANY IDENTIFICATION Product type: Finished Product Consumer (Retail) Use only Recommended use:
More informationInstitutional Review Board Standard Operating Procedure. Suspension and Termination of IRB Approval
Institutional Review Board Standard Operating Procedure University of Missouri-Columbia Suspension and Termination of IRB Approval Effective Date: May 31, 2006 Original Approval Date: May 31, 2006 Revision
More informationNPGA White Paper. OSHA Hazard Communication Standard
I. INTRODUCTION NPGA White Paper OSHA Hazard Communication Standard The purpose of this white paper is to describe the changes to the Occupational Safety and Health Administration (OSHA) Hazard Communication
More information1. Review and approval of the consent document is a responsibility that FDA assigns to the IRB with jurisdiction
Medical College of Wisconsin/Froedtert Hospital Guidance on Negotiating Consent Document Language For Clinical Trial Sponsors 1. Review and approval of the consent document is a responsibility that FDA
More informationWhat s New in GCP? FDA, OHRP Issue Harmonized Guidance on Transferring IRB Oversight of Clinical Studies
Vol. 8, No. 8, August 2012 Happy Trials to You What s New in GCP? FDA, OHRP Issue Harmonized Guidance on Transferring IRB Oversight of Clinical Studies Reprinted from the Guide to Good Clinical Practice
More informationIRB MEETING ADMINISTRATION
1. POLICY Steering Committee approved / Effective date: 9/11/15 Except when an expedited review procedure is appropriate or an exemption determination may be made, the IRB will review proposed research
More informationRESEARCH SUBMISSION REQUIREMENTS
1. POLICY IRB members rely primarily solely on the documentation submitted by investigators for initial and continuing review. Therefore this material must provide IRB members with enough information about
More informationDEPARTMENT OF HEALTH & HUMAN S E RVICES, 'mgr,':~~ MAY WARNING LETTE R
DEPARTMENT OF HEALTH & HUMAN S E RVICES, 'mgr,':~~ 'd Drug Admmi~';. ;!!Ion t, rpi~ratc Fli~ l, '.;';) _'tis4~tt MAY 15 2008 WARNING LETTE R VIA FEDERAL EXPRES S Robert Honeycutt/VP Ancillary Services
More informationSAFETY DATA SHEET Section 1: Product Identification
Product Name Identified Uses Supplier's Details SAFETY DATA SHEET Section 1: Product Identification Phone Number (519) 662-2877 Emergency Contact (24 Hrs) (613) 996-6666 CANUTEC Classification (GHS) GHS
More informationPOOL & SPA/HOT TUB APSP STANDARDS AS REFERENCED IN THE 2009 INTERNATIONAL CODES
POOL & SPA/HOT TUB APSP STANDARDS AS REFERENCED IN THE 2009 INTERNATIONAL CODES APSP Standards: As Referenced in the 2009 International Codes Publication Date: June 2010 ISBN-978-1-58001-662-9 PUBLISHED
More informationMSC Guidelines for Review of Inland Tank Barge Stability Procedure Number: C1-13 Revision Date: May 13, 2016
T. O. PHILLIPS, CDR, Chief, Tank Vessel and Offshore Division Purpose: To establish a process for reviewing stability calculations submitted to the MSC for Inland Tank Barges regulated under 46 CFR Subchapters
More informationDistributed by Kimball Midwest with the KM productidentification
The following SDS references the products below: Cleanser for Poison Ivy/Oak Towelette Vendor Part Number: 3018-06 Manufactured By: CoreTex Products, Inc. Distributed by Kimball Midwest with the KM productidentification
More informationHuman Research Protections Program Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital
Human Research Protections Program Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital To Whom It May Concern: The Medical College of Wisconsin (MCW) has an approved Federal Wide Assurance
More informationD³ IFA Enterovirus Duo Pack Safety Data Sheet Revision Date: October 17, Section 1 Product and Company Identification
Section 1 Product and Company Identification 1.1 Manufacturer Information Quidel Corporation Phone: 1.800.874.1517 Web: quidel.com 2005 East State Street, Suite 100 Fax: 1.740.592.9820 E-mail: qehs@quidel.com
More informationFDA s Guidance on Using a Centralized IRB Review Process in Multicenter Clinical Trials
FDA s Guidance on Using a Centralized IRB Review Process in Multicenter Clinical Trials Bridget Foltz Office of Good Clinical Practice Office of Medical Products and Tobacco Food and Drug Administration
More informationYale University Human Research Protection Program
Yale University Human Research Protection Program HRPP Policy 700 Noncompliance, Suspension and Termination Responsible Office Office of Research Administration Effective Date: February 10, 2009 Responsible
More informationBSR GPTC Z TR GM References and Reporting Page 1 of 8
Page 1 of 8 PRIMARY: 192.605 SECONDARY: 191.23 PURPOSE: Review guide material added by TR 2009-17 to 5.1(e) and consider restructuring the guide material under 192.605 as discussed further below. ORIGIN/RATIONALE
More informationIRB-REQUIRED INVESTIGATOR ACTIONS
Version No: 2 Effective Date: 11/01/02 Revised: 06/10/2005 09/08, 05/2009 1. POLICY IRB-REQUIRED INVESTIGATOR ACTIONS SOP: RI 801 Page 1 of 4 Between IRB initial approval of a protocol and the time of
More informationCAPA Plans: Solutions, not Blame
CAPA Plans: Solutions, not Blame Lorrie D. Divers, CCRP, RQAP-GCP Executive Director, Global Quality Assurance & Compliance ACM Medical Laboratory / ACM Global Central Laboratory Clinical Translation Science
More informationSAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING
SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Material HYCAMTIN INJECTABLE Synonyms HYCAMTIN INFUSION 1 MG/3 ML * HYCAMTIN INJECTION 1 MG/3 ML * HYCAMTIN
More informationQuickVue hcg Urine Test
Section 1 Product and Company Identification 1.1 Manufacturer Information Quidel Corporation Phone: 1.800.874.1517 Web: quidel.com 10165 McKellar Court Fax: 1.800.453.4338 E-mail: qehs@quidel.com San Diego,
More informationIssue in IRB Approvals:
Issue in IRB Approvals: What are the obligations of investigators and the IRB in maintaining IRB approval? What are the consequences of a lapse in IRB approval? How does the IRB evaluate lapses in approval?
More informationUNIVERSITY OF GEORGIA Institutional Review Board
UNIVERSITY OF GEORGIA Institutional Review Board Continuing Review Number: Date: Author: Approved By: Page(s): UGAHRP-057-2 01/20/2017 HSO IRB Page 1 of 7 1. PURPOSE 1.1. The UGA IRB has developed this
More informationBREEDING CONTRACT FROZEN SEMEN
Foothills Farm of Sedro-Woolley LLC Breeding Manager/Stallion Agent Kari Klingenberg 360-202-9008 BREEDING CONTRACT FROZEN SEMEN This contract dated this day of, 20 is between herein referred to as Mare
More informationENTRY GUIDELINES & CRITERIA DOES YOUR NEW BOAT OR PRODUCT QUALIFY?
48th Annual Official U.S. Debuts of 2019 Boats & Boating Products SEPTEMBER 13-16, 2018 NEWPORT, RHODE ISLAND ENTRY GUIDELINES & CRITERIA DOES YOUR NEW BOAT OR PRODUCT QUALIFY? Newport For New Products
More informationInfo Sheet - Operations Office for Human Research Studies
Guidance on Single IRB Review Process This document outlines how the DFCI IRB may rely on an external IRB to serve as the IRB of record for a DF/HCC site or Investigator. The Dana-Farber Cancer Institute
More informationRemoval of Lead-Based Paint
Safety Management System SP24-61 Process Authority: HS Manager Removal of Lead-Based Paint Approval: Chief Operating Officer Version Date:30/03/2015 Revision: B 1 Purpose To define the requirements for
More informationFDA > CDRH > CFR Title 21 Database Search. Registration Listing Adverse Events Advisory Committees. 21 CFR Part 56
Page 1 of 22 CDRH Home Search A-Z Index Feedback Prototype - for testing only 510 (k) CFR Title 21 Registration Listing Adverse Events Advisory Committees PMA Classification CLIA Assembler NHRIC Guidance
More informationRevision Date: 06-Aug-2015
SAFETY DATA SHEET Issuing Date: 27-May-2015 Version 1.02 This safety data sheet was developed based on regulations applicable to an industrial/occupational setting and may be applicable to Distribution
More informationSTALLION COOLED SEMEN CONTRACT
Page 1 Glenview Farm LLC Glenn Bouvier 6574 Dover Rd Shelbyville, KY 40065 (502) 647-0298 Alliance Stud LLC 1630 Todds Point Rd Simpsonville, KY 40067 (502) 722-0203 office (502) 817-5956 Linda Bennett
More informationSafety data sheet. Lubricant Lubricating grease
Safety data sheet Version:02.02/USA SECTION 1: Identification 1.1. Product identifier Trade name: LGFP 2 1.2. Relevant identified uses of the substance or mixture and uses advised against Recommended uses:
More informationIRB COMPOSITION AND IRB MEMBER ROLES AND RESPONSIBILITIES
IRB COMPOSITION AND IRB MEMBER ROLES AND RESPONSIBILITIES 1. Overview Each IRB must be appropriately constituted for the volume and types of human research to be reviewed, in accordance with federal regulations.
More informationLyra Direct Strep Assay
Section 1 Product and Company Identification 1.1 Manufacturer Information Quidel Corporation Phone: 1.800.874.1517 Web: quidel.com 2005 East State Street, Suite 100 Fax: 1.740.592.9820 E-mail: qehs@quidel.com
More informationBaptist Health Institutional Review Board. Study Closure Report (Expedited Review) IRB #: Study Title:
Baptist Health Institutional Review Board Study Closure Report (Expedited Review) (Please complete ALL sections of this form. Incomplete forms will be returned) Principal Investigator: E-mail: Phone #:
More informationFood and Drug Administration Center for Devices an d * 1Ya I a Radiological Health WARNING LETTE R
H yeavicts L r e DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Servic e 0r- 'ryj Food and Drug Administration Center for Devices an d * 1Ya I a Radiological Health 9200 Corporate Blvd Rockville,
More informationNot a dangerous substance or mixture according to the Globally Harmonized System (GHS).
1. PRODUCT AND COMPANY IDENTIFICATION Product name : IRDye 700 Phosphoramidite Part Number(s) : 830-05368, 4200-33, 4200-34 Brand : LI-COR Identified uses : Laboratory chemicals, Manufacture of substances
More informationMATERIAL SAFETY DATA SHEET according to the Hazard Communication Standard (29 CFR )
Date of issue: 12/12/2012 Version 1.0 SECTION 1. Identification Product identifier Product number 105741 Relevant identified uses of the substance or mixture and uses advised against Identified uses Details
More informationSTALLION COOLED SEMEN CONTRACT
P a g e 1 This form/contract certifies that STALLION COOLED SEMEN CONTRACT 1630 Todd s Point Road Simpsonville, KY 40067 502-722-0203 office / 502-817-5956 cell alliancestud@aol.com, herein referred to
More informationRoyal Vista Southwest PO Box 673 Purcell, OK Dear Client,
Royal Vista Southwest PO Box 673 Purcell, OK 73080 Dear Client, I have enclosed the Embryo Transfer contract(s) for the 2011 season. Please complete, sign and return together with the $1000 Booking Fee.
More informationENTRY GUIDELINES & CRITERIA DOES YOUR NEW BOAT OR PRODUCT QUALIFY?
48th Annual Official U.S. Debuts of 2019 Boats & Boating Products SEPTEMBER 13-16, 2018 NEWPORT, RHODE ISLAND ENTRY GUIDELINES & CRITERIA DOES YOUR NEW BOAT OR PRODUCT QUALIFY? Newport For New Products
More informationOHRP Guidance on Written IRB Procedures
Office for Human Research Protections (OHRP) Department of Health and Human Services Date: OHRP Guidance on Written IRB Procedures Scope: This document outlines the required elements of written Institutional
More informationIssuing Date: 04-Mar-2015 Revision Date: 04-Mar-2015 Version 1 1. IDENTIFICATION. Nioxin hairspray regular hold
SAFETY DATA SHEET Issuing Date: 04-Mar-2015 Version 1 1. IDENTIFICATION Product Name Product ID: Product Type: Recommended Use Synonyms Manufacturer E-mail Address Emergency Telephone Nioxin hairspray
More informationCentralized IRB Models
Centralized IRB Models NWABR / OHRP Conference July 31, 2014 James Riddle, MCSE, CIP, CPIA Assistant Director, Institutional Review Office Fred Hutchinson Cancer Research Center Outline Central IRB s Why
More informationSubmitting Continuing Reviews and/or Amendments to the IRB
Submitting Continuing Reviews and/or Amendments to the IRB Tufts-New England Medical Center Tufts University Health Sciences IRB Education Series 2006 Presentation may only be reused or reprinted with
More informationHumanitarian Use Devices Made Simple
May 25, 2017 Humanitarian Use Devices Made Simple Robert Romanchuk, BSHS, CIP, CCRC, CHRC, CCRCP IRB Vice Chairperson, Schulman IRB About Schulman IRB Established in 1983 Superior audit history with FDA
More informationCITES and ICCWC: Coordinated action to combat wildlife crime
1 st Meeting of the Intergovernmental Task Force on Illegal Killing, Taking and Trade of Migratory Birds in the Mediterranean 1 CITES and ICCWC: Coordinated action to combat wildlife crime Edward van Asch,
More informationHigh Density Calcium Silicate Fire Resistant Boards
SECTION 0. GENERAL INFORMATION This item meets the definition of article in the OSHA Hazard Communication Standard, 29 CFR 1910.1200. SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Trade name : Super Firetemp
More informationEffective Date: January 16, 2012 Policy Number: MHC_RP0107. Revised Date: November 2, 2015 Oversight Level: Corporate
Policy Title: Initial Review of Human Subject Research Effective Date: January 16, 2012 Policy Number: Review Date: November 20, 2015 Section: Revised Date: November 2, 2015 Oversight Level: Corporate
More informationUniversity of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Penn as Central IRB FAQ
Reliance Agreement Guidance: Penn as Central IRB FAQ This document is designed to answer questions frequently asked by individuals who want to know more about Penn s policies and procedures related to
More informationRoyal Vista Southwest th Street Purcell, OK Dear Client,
Royal Vista Southwest 26213 170 th Street Purcell, OK 73080 Dear Client, I have enclosed the Embryo Transfer contract(s) for the 2019 season. Please complete, sign and return together with the $1000 Annual
More informationSOP Title Review of Research: Devices for Humanitarian Uses
SOP Title Review of Research: Devices for Humanitarian Uses Purpose This document describes the National Jewish Health IRB review of Humanitarian Use Devices and Humanitarian Device Exemptions. Scope Humanitarian
More informationRoyal Vista Southwest th Street Purcell, OK Dear Client,
Royal Vista Southwest 26213 170 th Street Purcell, OK 73080 Dear Client, I have enclosed the Embryo Transfer contract(s) for the 2019 season. Please complete, sign and return together with the $1000 Annual
More informationKeele University Institute for Science and Technology in Medicine. Standard Operating Procedure. Title: Transportation of Human Tissue
Keele University Institute for Science and Technology in Medicine Standard Operating Procedure SOP Number: HTA-36 Version: 1.0 Title: Transportation of Human Tissue Purpose: To provide a standardised approach
More informationNONCOMPLIANCE. 1. Overview
NONCOMPLIANCE 1. Overview Investigators, research staff, the IRBs, (ORRP), and the organization share responsibility for the ethical conduct of human subjects research and for compliance with federal regulations,
More informationSAFETY DATA SHEET I. IDENTIFICATION OF THE PRODUCT AND RESPONSIBLE PARTY
SAFETY DATA SHEET I. IDENTIFICATION OF THE PRODUCT AND RESPONSIBLE PARTY Product Name: Schick Hydro Sensitive Skin Shave Gel Product Code(s): 112049 Recommended Use(s): Uses Advised Against: Contact Information
More informationMedical Gas Compliance Alert
31January2013 rev.7/14/2015 Medical Gas Compliance Alert Medical Gas Certification Important Compliance Alert Medical Gas Certification This GAWDA Medical Gas Compliance Alert is to inform GAWDA members
More informationTo assure knowledge and compliance by documenting the annual administrative review and continuing IRB review of non-exempt projects for the IRB.
Institutional Review Board.... University of Missouri-Columbia.. Standard Operating Procedure Annual Review of Research Annual Review of Research Effective Date: January 21, 2019 Original Approval Date:
More informationChildren s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Continuing Review of Approved Research
Page: 1 of 6 I. PURPOSE The purpose of this SOP is to describe the submission requirements for investigators and the review requirements for the IRB for the conduct of continuing review in accordance with
More informationUNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH
UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH I. PURPOSE This document outlines the University of Tennessee Health Science Center Institutional
More informationEXP-NBD103 Native Barcoding Kit 1D
EXP-NBD103 Native Barcoding Kit 1D Revision Date 27/11/2015 SAFETY DATA SHEET Native Barcode Adapters According to Regulation (EU) No 453/2010 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF
More informationGeneral Regulations for Areas Administered by the National Park Service and the Fish and Wildlife Service
4312-52-M DEPARTMENT OF THE INTERIOR National Park Service 36 CFR Part 2 Fish and Wildlife Service 50 CFR Part 27 RIN 1024-AD70 General Regulations for Areas Administered by the National Park Service and
More informationSAFETY DATA SHEET. Restrictions on use : Reserved for industrial and professional use. : ,
Section: 1. PRODUCT AND COMPANY IDENTIFICATION Product name : Other means of identification : Not applicable. Recommended use : Air Freshener Restrictions on use : Reserved for industrial and professional
More informationthe HRPP Director will prepare a draft report within three (3) workdays after the IRB meeting at which the determination occurred.
IRB Policy 34: Reporting Policy Revision Date: March 27, 2009, revised June 11, 2010, revised January 27, 2011, revised 9/23/13, revised 9/17/15, revised 4/2/18, revised 9/14/18 INSTITUTIONAL REVIEW BOARD
More information